Then, a recent bioinformatics analysis revealed similar evidence with our results, they found that elevated METTL16, YTHDC1, and YTHDC2 expression in prefrontal cortex of depressed patients and low IGF2BP1/2 expression in both normal and MDD patients [52]. Here, IGF2BP1 is linked to major depressive disorder.